Transcriptome of Two Canine Prostate Cancer Cells Treated With Toceranib Phosphate Reveals Distinct Antitumor Profiles Associated With the PDGFR Pathway

Canine prostate cancer (PC) presents a poor antitumor response, usually late diagnosis and prognosis. Toceranib phosphate (TP) is a nonspecific inhibitor of receptor tyrosine kinases (RTKs), including vascular endothelial growth factor receptor (VEGFR), platelet-derived growth factor receptor (PDGFR...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Priscila E., Lainetti, Patrícia F., Leis-Filho, Antonio F., Delella, Flávia K., Carvalho, Marcio, Cury, Sarah Santiloni, Carvalho, Robson Francisco, Fonseca-Alves, Carlos E., Laufer-Amorim, Renée
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Veterinary Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726326/
https://www.ncbi.nlm.nih.gov/pubmed/33324695
http://dx.doi.org/10.3389/fvets.2020.561212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726326/
https://www.ncbi.nlm.nih.gov/pubmed/33324695
http://dx.doi.org/10.3389/fvets.2020.561212

Ejemplares similares